Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer

Table 5 Relationships between clinicopathological factors of gastric cancer patients and anoctamin 5 expression

Variables		N	IHC score		P value
			High group ( 1.3)	Low group (< 1.3)
Total		195	58	137
Sex	Male	128	35	93	0.3262
	Female	67	23	44
Age	< 65	77	25	52	0.5246
	65	118	33	85
Tumor location	U	41	15	26	0.3367
	M, L	154	43	111
Tumor length (mm)	< 30	63	22	41	0.3158
	30	132	36	96
Histological type	tub1, tub2, pap	96	35	61	0.0596
	por, sig, muc	99	23	76
Lymphatic invasion	Negative	110	34	76	0.7529
	Positive	85	24	61
Venous invasion	Negative	131	38	93	0.7419
	Positive	64	20	44
pT	pT1-2	137	37	100	0.2312
	pT3-4	58	21	37
pN	pN0	139	40	99	0.7294
	pN1-3	56	18	38

IHC: Immunohistochemical; L: Lower; M: Middle; pap: muc: Mucinous adenocarcinoma; Papillary adenocarcinoma; pN: pathological N stage; por: Poorly differentiated adenocarcinoma; pT: pathological T stage; sig: Signet-ring cell carcinoma;tub: Tubular adenocarcinoma; U: Upper.